Brief Summary
Type:
Multiple Myeloma
Study Type:
Other
Phase:
I
ClinicalTrials.gov Identifier:
NCT03741127
Study #:
STUDY00146670
Start Date:
Mar 31, 2022
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03741127
View Complete Trial Details & Eligibility at ClinicalTrials.gov
